白细胞介素18单核苷酸多态性与73例喉鳞状细胞癌易感性的关联性

doi:10.6040/j.issn.1671-7554.0.2020.137

摘要/Abstract

摘要： 目的探讨白细胞介素18(IL-18)启动子位点-137G/C和-607C/A基因多态性与山东地区汉族人群喉鳞状细胞癌(LSCC)易感性的关系。方法随机选取2017年5月至2019年10月就诊于临沂市人民医院的喉鳞状细胞癌患者73例为病例组,选取同期查体的健康志愿者73人为健康对照组。收集研究对象一般临床资料及外周静脉血2 mL,提取全血DNA,采用sanger测序法进行基因测序及SNP分型。所有定量资料采用Students-t检验分析,定性资料采用Pearson χ2检验或Fisher精确检验,应用卡方拟合优度检验分析健康对照组是否符合Hardy-Weinberg平衡定律,采用二元Logistic回归分析计算两种单核苷酸多态性(SNP)位点以及各风险因素(年龄、吸烟、饮酒)与LSCC发病风险的关联性。结果与健康对照组相比,病例组中-137G/C位点变异基因型GC的基因型频率升高(34.2% vs 19.2%, P=0.040),而-607C/A 位点各基因型频率的分布在病例组和健康对照组之间差异无统计学意义(P>0.05)。吸烟及饮酒均会升高LSCC的发病风险(OR分别为5.710和3.116)。对基因型、年龄组、吸烟史及饮酒史4种风险因素进行调整后,吸烟者与-137G/C基因型携带者LSCC发病风险的OR值分别为4.967(95%CI=2.185~11.289, P<0.001)和2.971(95%CI=1.243~7.101, P=0.014),差异有统计学意义。结论 IL-18启动子位点-137G/C而非-607C/A的多态性与LSCC的患病风险升高有关联性。

关键词: 喉鳞状细胞癌, 单核苷酸多态性, 白细胞介素18, 易感性, 风险因素

Abstract: Objective To investigate the correlation between interleukin-18(IL-18)and promotors -137G/C and -607C/A gene polymorphisms and the susceptibility of laryngeal squamous cell carcinoma(LSCC)in a Chinese Han population in Shandong Province. Methods A total of 73 LSCC patients(case group)treated at Linyi Peoples Hospital during May 2017 and Oct. 2019 and 73 healthy controls were enrolled. The clinical information and peripheral venous blood samples(2 mL)were collected. The whole blood DNA was extracted, and gene sequencing and SNP genotyping 山东大学学报 (医学版)58卷9期 -孟朝暾,等.白细胞介素18单核苷酸多态性与73例喉鳞状细胞癌易感性的关联性 \=-were conducted. The quantitative data were analyzed with Students-t test, and the qualitative data were analyzed with Pearson χ² test or Fisher exact test. The control group was analyzed with chi-square goodness of fit test to verify whether it was in accordance with the Hardy-Weinberg equilibrium law. The correlation between two SNP loci and risk factors(age, smoking, drinking)with LSCC risk was determined with binary Logistic regression analysis. Results The case group had higher genotype frequency of GC at -137G/C(34.2% vs 19.2%, P=0.040), but there was no significant difference in the genotype frequency at -607C/A between the two groups(P>0.05). Smoking and drinking increased the risk of LSCC(OR=5.710; 3.116). After the risk factors of genotype, age, smoking and drinking history were adjusted, the OR of LSCC risk in smokers and -137G/C carriers were 4.967(95%CI=2.185-11.289, P<0.001)and 2.971(95%CI=1.243-7.101, P=0.014), respectively. Conclusion Our findings suggest that IL-18 promoter -137G/C polymorphism is correlated with an increased risk of LSCC.

Key words: Laryngeal squamous cell carcinoma, Single nucleotide polymorphism, Interleukins-18, Susceptibility, Risk factor

中图分类号:

R767

孟朝暾,李钦, 孙卉,邬信芳,孙文凯,高伟. 白细胞介素18单核苷酸多态性与73例喉鳞状细胞癌易感性的关联性[J]. 山东大学学报 (医学版), 2020, 58(9): 58-63.

MENG Zhaotun, LI Qin, SUN Hui, WU Xinfang, SUN Wenkai, GAO Wei. Correlation between interleukin-18 single nucleotide polymorphism and susceptibility of laryngeal squamous cell carcinoma: a report of 73 cases[J]. Journal of Shandong University (Health Sciences), 2020, 58(9): 58-63.

参考文献 31

[1]	Rudolph E, Dyckhoff G, Becher H, et al. Effects of tumour stage, comorbidity and therapy on survival of laryngeal cancer patients: a systematic review and a meta-analysis[J]. Eur Arch Otorhinolaryngol, 2011, 268(2): 165-179.
[2]	Marioni G, Marchese-Ragona R, Cartei G, et al. Current opinion in diagnosis and treatment of laryngeal carcinoma[J]. Cancer Treat Rev, 2006, 32(7): 504-515.
[3]	Markou K, Christoforidou A, Karasmanis I, et al. Laryngeal cancer: epidemiological data from Nuorthern Greece and review of the literature[J]. Hippokratia, 2013, 17(4): 313-318.
[4]	中华耳鼻咽喉头颈外科杂志编辑委员会头颈外科组, 中华医学会耳鼻咽喉头颈外科学分会头颈学组,李晓明. 喉癌外科手术及综合治疗专家共识[J]. 中华耳鼻咽喉头颈外科杂志, 2014, 49(8): 620-626.
[5]	Hah JH, Sim S, An SY, et al. Evaluation of the prevalence of and factors associated with laryngeal diseases among the general population[J]. Laryngoscope, 2015, 125(11): 2536-2542.
[6]	Islami F, Tramacere I, Rota M, et al. Alcohol drinking and laryngeal cancer: overall and dose-risk relation—a systematic review and meta-analysis[J]. Oral Oncol, 2010, 46(11): 802-810.
[7]	Si FZ, Feng YQ, Han M. Association between interleukin-17 gene polymorphisms and the risk of laryngeal cancer in a Chinese population[J]. Genet Mol Res, 2017, 16(1). doi: 10.4238/gmr16019076.
[8]	Su J, Cui J, Xue HT, et al. Study on the correlation between CD14 gene polymorphism and susceptibility to laryngeal cancer[J]. Eur Rev Med Pharmacol Sci, 2017, 21(19): 4292-4297.
[9]	Vijay PR, Kumar R, Bhatt M, et al. To investigate the affiliation of XRCC-1 Gene Arg194Trp polymorphism in alcohol and tobacco substance users and loco-regionally progressed Laryngeal squamous cell carcinoma[J]. J Oral Biol Craniofac Res, 2019, 9(1): 77-80.
[10]	李大鹏, 黄辉, 柴伟, 等. hOGG1基因多态性与喉癌易感性的相关性分析[J]. 中华耳鼻咽喉头颈外科杂志, 2016, 51(9): 681-684. LI Dapeng, HUANG Hui, CHAI Wei, et al. Analysis of association of human 8-oxoguanine giycosylase 1 polymorphism with the susceptibility of laryngeal cancer[J]. Chinese Journal of Otorhinolaryngology Head and Neck Surgery, 2016, 51(9): 681-684.
[11]	Nolan KF, Greaves DR, Waldmann H. The human interleukin 18 gene IL18 maps to 11q22.2-q22.3, closely linked to the DRD2 gene locus and distinct from mapped IDDM loci[J]. Genomics, 1998, 51(1): 161-163.
[12]	Back LK, Farias TD, Da CP, et al. Functional polymorphisms of interleukin-18 gene and risk of breast cancer in a Brazilian population[J]. Tissue Antigens, 2014, 84(2): 229-233.
[13]	Dwivedi S, Goel A, Mandhani A, et al. Functional genetic variability at promoters of pro-(IL-18)and anti-(IL-10)inflammatory affects their mRNA expression and survival in prostate carcinoma patients: Five year follow-up study[J]. Prostate, 2015, 75(15): 1737-1746.
[14]	Chang WS, Shen TC, Yeh WL, et al. Contribution of inflammatory cytokine interleukin-18 genotypes to renal cell carcinoma[J]. Int J Mol Sci, 2019, 20(7): 1563.
[15]	樊春波, 王晶, 蒋勇, 等. ApoE和IL-18基因多态性与脑胶质瘤发生的临床关系[J]. 基因组学与应用生物学, 2018, 37(10): 4574-4580. FAN Chunbo, WANG Jing, JIANG Yong, et al. The clinical relationship between ApoE and IL-18 gene polymorphism and brain glioma[J]. Genomics and Applied Biology, 2018, 37(10): 4574-4580.
[16]	Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM[J]. Ann Surg Oncol, 2010, 17(6): 1471-1474.
[17]	Zhou J, Zhang D, Zhou L, et al. Association of the recurrence and canceration rate of vocal leukoplakia with interleukin-10 promoter variants over a 2-year period[J]. Acta Otolaryngol, 2016, 136(11): 1147-1153.
[18]	麦家豪, 马玲国. 人乳头状瘤病毒与喉癌的相关性研究现状[J]. 中华耳鼻咽喉头颈外科杂志, 2019, 54(5): 385-388. MAI Jiahao, MA Lingguo. Human papillomavirus and laryngeal cancer[J]. Chinese Journal of Otorhinolaryngology Head and Neck Surgery, 2019, 54(5): 385-388.
[19]	Fang R, Huang Y, Xie J, et al. Downregulation of miR-29c-3p is associated with a poor prognosis in patients with laryngeal squamous cell carcinoma[J]. Diagn Pathol, 2019, 14(1): 109.
[20]	李钦, 王凌荣, 陈彦林, 等. 谷胱苷肽S转移酶M1和T1基因多态性与喉及下咽癌易感性的关系[J]. 临床耳鼻咽喉头颈外科杂志, 2009, 23(24): 1105-1107. LI Qin, WANG Lingrong, CHEN Yanlin, et al. Polymorphisms of GSTM1, GSTT1 and susceptibility of laryngeal and hypopharyngeal carcinomas[J]. Journal of Clinical Otorhinolaryngology, 2009, 23(24): 1105-1107.
[21]	Bakr NM, Awad A, Moustafa EA. Association of genetic variants in the interleukin-18 gene promoter with risk of hepatocellular carcinoma and metastasis in patients with hepatitis C virus infection[J]. IUBMB Life, 2018, 70(2): 165-174.
[22]	Gunel N, Coskun U, Sancak B, et al. Clinical importance of serum interleukin-18 and nitric oxide activities in breast carcinoma patients[J]. Cancer, 2002, 95(3): 663-667.
[23]	Farhat K, Hassen E, Bouzgarrou N, et al. Functional IL-18 promoter gene polymorphisms in Tunisian nasopharyngeal carcinoma patients[J]. Cytokine, 2008, 43(2): 132-137.
[24]	Martone T, Bellone G, Pagano M, et al. Constitutive expression of interleukin-18 in head and neck squamous carcinoma cells[J]. Head Neck, 2004, 26(6): 494-503.
[25]	Giedraitis V, He B, Huang WX, et al. Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation[J]. J Neuroimmunol, 2001, 112(1-2): 146-152.
[26]	Li X, Ren D, Li Y, et al. Increased cancer risk associated with the -607C/A polymorphism in interleukin-18 gene promoter: an updated meta-analysis including 12,502 subjects[J]. J BUON, 2015, 20(3): 902-917.
[27]	Asefi V, Mojtahedi Z, Khademi B, et al. Head and neck squamous cell carcinoma is not associated with interleukin-18 promoter gene polymorphisms: a case-control study[J]. J Laryngol Otol, 2009, 123(4): 444-448.
[28]	Jurecekova J, Babusikova E, Kmetova SM, et al. Association between interleukin-18 variants and prostate cancer in Slovak population[J]. Neoplasma, 2017, 64(1): 148-155.
[29]	Nong LG, Luo B, Zhang L, et al. Interleukin-18 gene promoter polymorphism and the risk of nasopharyngeal carcinoma in a Chinese population[J]. DNA Cell Biol, 2009, 28(10): 507-513.
[30]	Singh PK, Ahmad MK, Kumar V, et al. Effects of interleukin-18 promoter(C607A and G137C)gene polymorphisms and their association with oral squamous cell carcinoma(OSCC)in northern India[J]. Tumour Biol, 2014, 35(12): 12275-12284.
[31]	杨丽娟, 温树信, 林佳, 等. CD14启动子区遗传变异对喉癌遗传易感性的影响[J]. 中华耳鼻咽喉头颈外科杂志, 2016, 51(3): 197-202. YANG Lijuan, WEN Shuxin, LIN Jia, et al. Effect of CD14 promoter variants on the susceptibility to laryngeal cancer[J]. Chinese Journal of Otorhinolaryngology Head and Neck Surgery, 2016, 51(3): 197-202.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed